WHO ICTRP trial

Comparative study on the early prognosis of initial dialysis patients between…

ChiCTR2100054573 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2100054573
Public title Comparative study on the early prognosis of initial dialysis patients between the new sequential induction therapy of blood purification and the traditional induction dialysis
Scientific title Comparative study on the early prognosis of initial dialysis patients between the new sequential induction therapy of blood purification and the traditional induction dialysis
Primary sponsor The Second Affiliated Hospital of Nanchang University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Phase 0
Countries China
Conditions End-stages renal disease
Interventions Control group:Traditional hemodialysis induced dialysis therapy;Experimental group:New sequential induction therapy of CRRT, hemodiafiltration and hemodialysis
Registration date Dec 20, 2021
Target size Control group:252;Experimental group:252
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations